Evolution Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Evolution Advisers's LLY Position: Q3 2026 in Review
Evolution Advisers sold out of Eli Lilly (LLY) in Q3 2026, closing a stake of 3 shares — an estimated $3K sold.
Evolution Advisers first reported a position in LLY in Q4 2021 and held it in 2 quarters. The position peaked at $20K in Q4 2021. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Evolution Advisers reported no remaining Eli Lilly position as of Q3 2026 after selling out during the quarter.
- Evolution Advisers sold 3 Eli Lilly shares in Q3 2026, an estimated $3K.
- Evolution Advisers first reported a position in Eli Lilly in Q4 2021 and held it in 2 quarters.
- Evolution Advisers's Eli Lilly position peaked at $20K in Q4 2021.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.